Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.69 is 51% below its 5-year average of 3.43, near the low end of its 5-year range (1.50–11.18).
As of the fiscal period ended Tuesday, June 30, 2026. 6.30% below its 12-month average of 1.80.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.69.
QUICK RATIO (ACID-TEST)
1.69
QUICK RATIO (ACID-TEST) AVG TTM
1.80
QUICK RATIO (ACID-TEST) AVG 3Y
2.79
QUICK RATIO (ACID-TEST) AVG 5Y
3.43
QUICK RATIO (ACID-TEST) AVG 10Y
3.52
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.30%
CURRENT VS 3Y AVG
-39.66%
CURRENT VS 5Y AVG
-50.90%
CURRENT VS 10Y AVG
-52.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-49.67%
vs the sector median at left
Neuronetics, Inc.
Market Cap
$154.14M
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.80
3Y Avg
2.79
5Y Avg
3.43
Market Cap
$152.82M
Quick Ratio (Acid-Test)
0.45
TTM Avg
0.24
3Y Avg
0.20
5Y Avg
0.38
Market Cap
$149.06M
Quick Ratio (Acid-Test)
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.44
Market Cap
$159.22M
Quick Ratio (Acid-Test)
0.84
TTM Avg
0.97
3Y Avg
0.83
5Y Avg
1.00
Market Cap
$148.27M
Quick Ratio (Acid-Test)
2.99
TTM Avg
3.92
3Y Avg
3.42
5Y Avg
4.30
Market Cap
$148.69M
Quick Ratio (Acid-Test)
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$148.48M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$160.08M
Quick Ratio (Acid-Test)
20.14
TTM Avg
22.07
3Y Avg
21.46
5Y Avg
19.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuronetics, Inc. (STIM) | $154.14M | 1.69 | 1.80 | 2.79 | 3.43 |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | 0.45 | 0.24 | 0.20 | 0.38 |
| Inogen, Inc. (INGN)vs › | $156.90M | 2.34 | 2.40 | 2.87 | 3.55 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $149.06M | 5.55 | 4.34 | 4.83 | 5.44 |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | 0.84 | 0.97 | 0.83 | 1.00 |
| Codexis, Inc. (CDXS)vs › | $148.27M | 2.99 | 3.92 | 3.42 | 4.30 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $148.69M | 9.71 | 4.67 | 6.04 | 19.74 |
| Veraxa Biotech Holding AG (VRXA)vs › | $148.48M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.08M | 20.14 | 22.07 | 21.46 | 19.43 |
| PepGen Inc. (PEPG)vs › | $159.44M | 13.36 | 9.68 | 8.92 | 10.26 |
Quick Ratio
1.69
Excludes inventory
Current Ratio
1.88
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.69 |
| 2026-03-31 | 1.50 |
| 2025-12-31 | 1.87 |
| 2025-09-30 | 2.09 |
| 2025-06-30 | 1.84 |
| 2025-03-31 | 2.28 |
| 2024-12-31 | 1.72 |
| 2024-09-30 | 2.87 |
| 2024-06-30 | 2.37 |
| 2024-03-31 | 5.18 |
| 2023-12-31 | 4.33 |
| 2023-09-30 | 4.00 |
| 2023-06-30 | 4.58 |
| 2023-03-31 | 4.76 |
| 2022-12-31 | 2.71 |
| 2022-09-30 | 3.68 |
| 2022-06-30 | 4.64 |
| 2022-03-31 | 7.25 |
| 2021-12-31 | 6.93 |
| 2021-09-30 | 2.39 |
| 2021-06-30 | 11.18 |
| 2021-03-31 | 12.24 |
| 2020-12-31 | 4.48 |
| 2020-09-30 | 1.34 |
| 2020-06-30 | 1.41 |
| 2020-03-31 | 5.94 |
| 2019-12-31 | 3.09 |
| 2019-09-30 | 4.23 |
| 2019-06-30 | 5.95 |
| 2019-03-31 | 8.74 |
| 2018-12-31 | 8.26 |
| 2018-09-30 | 7.46 |
| 2018-06-30 | 1.59 |
| 2018-03-31 | 2.65 |
| 2017-12-31 | 2.88 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
